Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practical considerations for BNP use.

Clyde W Yancy1

  • 1UT Southwestern Medical Center, Dallas, TX 75390-9047, USA. Clyde.yancy@utsouthwestern.edu

Heart Failure Reviews
|October 24, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Posttraumatic Stress Disorder and Cardiovascular Disease: State of the Science, Knowledge Gaps, and Research Opportunities.

JAMA cardiology·2021
Same author

Association Between Neighborhood-Level Poverty and Incident Atrial Fibrillation: a Retrospective Cohort Study.

Journal of general internal medicine·2021
Same author

Temporal Associations Between Immunization With the COVID-19 mRNA Vaccines and Myocarditis: The Vaccine Safety Surveillance System Is Working.

JAMA cardiology·2021
Same author

Preventable Deaths From Heart Disease and Stroke Among Racial and Ethnic Minorities in the United States.

Circulation. Cardiovascular quality and outcomes·2021
Same author

The Journey Toward Health Equity: Are We Nearing an Abyss or Ascending a Peak?

Circulation·2021
Same author

Equity and the JAMA Network.

JAMA oncology·2021
Same journal

Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathy.

Heart failure reviews·2026
Same journal

Beyond vasodilation: sotatercept and the remodeling hypothesis in hfpef-associated pulmonary hypertension.

Heart failure reviews·2026
Same journal

Beyond the right ventricle: left heart involvement in pulmonary arterial hypertension.

Heart failure reviews·2026
Same journal

Left ventricular non-compaction in heart failure: contemporary perspective on diagnostic challenges and treatment opportunities.

Heart failure reviews·2026
Same journal

Correction to: Left atrial shunting devices: why, what, how, and… when?

Heart failure reviews·2026
Same journal

Cardiac microcurrent therapy in heart failure: Mechanistic rationale, early clinical evidence, and future directions.

Heart failure reviews·2026
See all related articles

B-type natriuretic peptide (BNP) is a key marker for diagnosing and assessing heart failure severity. Elevated BNP levels indicate left ventricular dysfunction and remodeling, guiding tailored heart failure therapies.

Area of Science:

  • Cardiology
  • Biomarkers
  • Heart Failure Research

Background:

  • Heart failure management is evolving with new understanding of neurohormonal factors.
  • B-type natriuretic peptide (BNP) demonstrates favorable neurohormonal, structural, and hemodynamic properties.

Purpose of the Study:

  • To highlight the diagnostic, prognostic, and monitoring utility of BNP in heart failure.
  • To explore emerging applications of BNP in clinical practice and therapy.

Main Methods:

  • The abstract discusses the role of BNP as a marker for left ventricular dysfunction.
  • It reviews how BNP levels correlate with disease severity and left ventricular remodeling.
  • Consideration is given to factors influencing BNP levels, such as gender, disease state, and obesity.

Related Experiment Videos

Main Results:

  • BNP serves as a practical tool for heart failure diagnosis and severity tracking.
  • Elevated BNP levels are indicative of left ventricular stress and remodeling.
  • BNP's utility extends to clinical assessment, post-myocardial infarction evaluation, and targeted therapy.

Conclusions:

  • BNP is a valuable biomarker in the current paradigm of heart failure management.
  • Further applications of BNP are anticipated, including its use in tailored treatment strategies.
  • New heart failure biomarkers are emerging, but their clinical roles are yet to be defined.